Edinburgh Research Explorer

Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies

Research output: Contribution to journalReview article

Standard

Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies. / De Sousa, Paul A.; Ritchie, Diane; Green, Alison; Chandran, Siddharthan; Knight, Richard; Head, Mark W.

In: Acta Neuropathologica, 27.11.2018.

Research output: Contribution to journalReview article

Harvard

De Sousa, PA, Ritchie, D, Green, A, Chandran, S, Knight, R & Head, MW 2018, 'Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies', Acta Neuropathologica. https://doi.org/10.1007/s00401-018-1941-9

APA

De Sousa, P. A., Ritchie, D., Green, A., Chandran, S., Knight, R., & Head, M. W. (2018). Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies. Acta Neuropathologica. https://doi.org/10.1007/s00401-018-1941-9

Vancouver

De Sousa PA, Ritchie D, Green A, Chandran S, Knight R, Head MW. Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies. Acta Neuropathologica. 2018 Nov 27. https://doi.org/10.1007/s00401-018-1941-9

Author

De Sousa, Paul A. ; Ritchie, Diane ; Green, Alison ; Chandran, Siddharthan ; Knight, Richard ; Head, Mark W. / Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies. In: Acta Neuropathologica. 2018.